Key facts
- This page summarizes Jonathan Sheena's Form 4 filing for Natera, Inc. (NTRA).
- 11 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 26 Jul 2021, 18:07.
Jonathan Sheena - 22 Jul 2021 Form 4 Insider Report for Natera, Inc. (NTRA)
- Reporting relationship
- Director, CO-FOUNDER
- Issuer ticker
- NTRA
- Reported as of
- 22 Jul 2021
- Net transaction value
- -$152,403
- SEC form
- 4
- Accepted by SEC
- 26 Jul 2021, 18:07:56 UTC
- Prior SEC filing
- 13 Jul 2021
- Next SEC filing
- 01 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tami Chen, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan Sheena filed Form 4 for Natera, Inc. (NTRA) on 26 Jul 2021.
Change
- Previous filing in this sequence was filed on 13 Jul 2021.
- Current net transaction value: -$152,403.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NTRA
transaction
Common Stock
Options Exercise
- Transaction value
- $1,009
- Shares
- +187
- Change %
- +0.04%
- Price
- $5.40*
- Shares after
- 455,817
- Date
- 22 Jul 2021
- Ownership
- Direct
NTRA
transaction
Common Stock
Options Exercise
- Transaction value
- $623
- Shares
- +65
- Change %
- +0.01%
- Price
- $9.59*
- Shares after
- 455,882
- Date
- 22 Jul 2021
- Ownership
- Direct
NTRA
transaction
Common Stock
Options Exercise
- Transaction value
- $4,164
- Shares
- +400
- Change %
- +0.09%
- Price
- $10.41*
- Shares after
- 456,282
- Date
- 22 Jul 2021
- Ownership
- Direct
NTRA
transaction
Common Stock
Options Exercise
- Transaction value
- $6,503
- Shares
- +700
- Change %
- +0.15%
- Price
- $9.29*
- Shares after
- 456,982
- Date
- 22 Jul 2021
- Ownership
- Direct
NTRA
transaction
Common Stock
Sale
- Transaction value
- $107,646
- Shares
- -887
- Change %
- -0.19%
- Price
- $121.36
- Shares after
- 456,095
- Date
- 22 Jul 2021
- Ownership
- Direct
- Footnotes
- F1, F2
NTRA
transaction
Common Stock
Sale
- Transaction value
- $36,709
- Shares
- -300
- Change %
- -0.07%
- Price
- $122.36
- Shares after
- 455,795
- Date
- 22 Jul 2021
- Ownership
- Direct
- Footnotes
- F1, F3
NTRA
transaction
Common Stock
Sale
- Transaction value
- $20,346
- Shares
- -165
- Change %
- -0.04%
- Price
- $123.31
- Shares after
- 455,630
- Date
- 22 Jul 2021
- Ownership
- Direct
- Footnotes
- F1, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NTRA
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -187
- Change %
- -12%
- Price
- $0.000000
- Shares after
- 1,328
- Date
- 22 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 187
- Exercise price
- $5.40
- Footnotes
- F5
NTRA
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -65
- Change %
- -0.16%
- Price
- $0.000000
- Shares after
- 40,335
- Date
- 22 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 65
- Exercise price
- $9.59
- Footnotes
- F6
NTRA
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -400
- Change %
- -1.1%
- Price
- $0.000000
- Shares after
- 35,280
- Date
- 22 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 400
- Exercise price
- $10.41
- Footnotes
- F7
NTRA
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -700
- Change %
- -3.9%
- Price
- $0.000000
- Shares after
- 17,346
- Date
- 22 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 700
- Exercise price
- $9.29
- Footnotes
- F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
Footnote F2
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.15 to $122.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.19 to $123.52 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F5
The option shares vested fully and became exercisable on November 20, 2019.
Footnote F6
The option shares vested fully and became exercisable on April 1, 2020.
Footnote F7
The option shares vested fully and became exercisable on March 21, 2021.
Footnote F8
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.